Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis

被引：0

作者：

Gugliotta, Gabriele ^{[1
]}

Castagnetti, Fausto ^{[1
]}

Breccia, Massimo ^{[2
]}

Levato, Luciano ^{[3
]}

Rege-Cambrin, Giovanna ^{[4
]}

Luciano, Luigiana ^{[5
]}

Bocchia, Monica ^{[6
]}

Rossi, Antonella Russo ^{[7
]}

Usala, Emilio ^{[8
]}

Salvucci, Marzia ^{[9
]}

Gozzini, Antonella ^{[10
]}

Binotto, Gianni ^{[11
]}

Cedrone, Michele ^{[12
]}

Abruzzese, Elisabetta ^{[13
]}

Avanzini, Paolo ^{[14
]}

Venturi, Claudia ^{[1
]}

Testoni, Nicoletta ^{[1
]}

Soverini, Simona ^{[1
]}

Alimena, Giuliana ^{[2
]}

Cavo, Michele ^{[1
]}

Martinelli, Giovanni ^{[1
]}

Pane, Fabrizio ^{[15
]}

Saglio, Giuseppe ^{[16
]}

Baccarani, Michele ^{[17
]}

Rosti, Gianantonio ^{[1
]}

机构：

[1] Univ Bologna, Sch Med, Bologna, Italy

[2] Univ Roma La Sapienza, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Orbassano, Italy

[5] Univ Naples Federico II, Naples, Italy

[6] Univ Siena, I-53100 Siena, Italy

[7] Univ Bari, Bari, Italy

[8] Osped Oncol A Businco, UO Ematol & CTMO, Cagliari, Italy

[9] Osped Santa Maria delle Croci, Ravenna, Italy

[10] AOU Careggi, Florence, Italy

[11] Univ Padua, Padua, Italy

[12] Azienda Osped S Giovanni Addolorata, Rome, Italy

[13] Osped S Eugenio, Rome, Italy

[14] Azienda Osped S Maria Nuova, Reggio Emilia, Italy

[15] Univ Naples Federico II, Naples, Italy

[16] Univ Turin, Osped San Luigi Gonzaga, Dept Clin & Biol Sci, Orbassano, Italy

[17] Univ Bologna, Bologna, Italy

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] COST-UTILITY ANALYSIS OF NILOTINIB COMPARED TO IMATINIB FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE
Inocencio, T. J.
Seetasith, A.
Newland, A.
Bose, P.
Holdford, D.
VALUE IN HEALTH, 2012, 15 (04) : A223 - A223
[22] Five-Year Results of Nilotinib 400 Mg BID in Early Chronic Phase Chronic Myeloid Leukemia (CML): High Rate of Deep Molecular Response - Update of the Gimema CML WP Trial CML0307
Rosti, Gianantonio
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Levato, Luciano
Rege-Cambrin, Giovanna
Capucci, Adele
Tiribelli, Mario
Zaccaria, Alfonso
Bocchia, Monica
Stagno, Fabio
Cavazzini, Francesco
Specchia, Giorgina
Martino, Bruno
Cedrone, Michele
Intermesoli, Tamara
Palandri, Francesca
Soverini, Simona
Bochicchio, Maria Teresa
Testoni, Nicoletta
Alimena, Giuliana
Pane, Fabrizio
Saglio, Giuseppe
Martinelli, Giovanni
Baccarani, Michele
BLOOD, 2012, 120 (21)
[23] Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis
Castagnetti, Fausto
Testoni, Nicoletta
Luatti, Simona
Marzocchi, Giulia
Mancini, Marco
Kerim, Simonetta
Giugliano, Emilia
Albano, Francesco
Cuneo, Antonio
Abruzzese, Elisabetta
Martino, Bruno
Palandri, Francesca
Amabile, Marilina
Iacobucci, Ilaria
Alimena, Giuliana
Pane, Fabrizio
Martinelli, Giovanni
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2748 - 2754
[24] Comparison of cytogenetics and interphase fluorescence in situ hybridization in newly diagnosed Ph plus chronic myeloid leukemia patients treated with imatinib mesylate. A study by the GIMEMA working party on CML. On behalf of GWP on CML.
Testoni, N
Luatti, S
Nicci, C
Montanari, E
Marzocchi, G
Specchia, G
Mancini, M
Abruzzese, E
Rege-Cambrin, G
Cuneo, A
Kerim, S
Giussani, U
Bernasconi, P
Mecucci, C
Zaccaria, A
Discepoli, G
Martinelli, G
Rosti, G
Baccarani, M
BLOOD, 2005, 106 (11) : 294B - 294B
[25] LONG-TERM OUTCOME OF ALTERNATING NILOTINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY AS FRONTLINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: A PHASE 2 STUDY OF THE GIMEMA CML WORKING PARTY
Gugliotta, G.
Castagnetti, F.
Breccia, M.
Gozzini, A.
Stagno, F.
Rege-Cambrin, G.
Carella, A. M.
Luciano, L.
Abruzzese, E.
Martino, B.
Usala, E.
Rossi, G.
Bocchia, M.
Cavazzini, F.
Tiribelli, M.
Luatti, S.
Venturi, C.
Soverini, S.
Cavo, M.
Specchia, G.
Alimena, G.
Pane, F.
Martinelli, G.
Saglio, G.
Rosti, G.
Baccarani, M.
HAEMATOLOGICA, 2015, 100 : 131 - 131
[26] Nilotinib 800 mg daily as first line treatment of chronic myeloid leukemia in early chronic phase: results of a phase II trial of the GIMEMA CML Working Party
Rosti, G.
Castagnetti, F.
Palandri, F.
Pane, F.
Martinelli, G.
Saglio, G.
Baccarani, M.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[27] NILOTINIB 800 MG DAILY AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN EARLY CHRONIC PHASE: RESULTS OF A PHASE 2 TRIAL OF THE GIMEMA CML WORKING PARTY
Rosti, G.
Castagnetti, E.
Palandri, E.
Breccia, M.
Levato, L.
Capucci, A.
Tiribelli, M.
Alimena, G.
Stagno, F.
Rondoni, M.
Alberti, D.
Marzocchi, G.
Luatti, S.
Amabile, M.
Poerio, A.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 161 - 161
[28] NILOTINIB 800 MG DAILY IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: 12-MONTHS RESULTS OF A PHASE 2 TRIAL OF THE GIMEMA CML WORKING PARTY
Rosti, G.
Castagnetti, F.
Breccia, M.
Poerio, A.
Gugliotta, G.
Levato, L.
Palandri, F.
Capucci, A.
Tiribelli, M.
Stagno, F.
Marzocchi, G.
Luatti, S.
Amabile, M.
Zaccaria, A.
Alimena, G.
Pane, F.
Martinelli, G.
Saglio, G.
Baccarani, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 440 - 440
[29] Efficacy of Frontline Nilotinib Therapy in Patients. (Pts) with Newly Diagnosed Philadelphia Chromosome (Ph)-Positive Chronic Myeloid Leukemia in Early Chronic Phase (CML-CP)
Quintas-Cardama, Alfonso
Kantarjian, Hagop M.
Luthra, Rajyalakshmi
O'Brien, Susan
Jabbour, Elias
Borthakur, Gautam
Ravandi, Farhad
Garcia-Manero, Guillermo
Faderl, Stefan
Konopleva, Marina
Wierda, William G.
Burton, Elizabeth
Cortes, Jorge E.
BLOOD, 2011, 118 (21) : 210 - 210
[30] NILOTINIB 400 MG BID AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA IN EARLY CHRONIC PHASE: RESULTS OF A PHASE 2 TRIAL OF THE GIMEMA CML WORKING PARTY
Castagnetti, F.
Palandri, F.
Poerio, A.
Breccia, M.
Levato, L.
Capucci, A.
Tiribelli, M.
Stagno, F.
Zaccaria, A.
Marzocchi, G.
Luatti, S.
Amabile, M.
Martinelli, G.
Alimena, G.
Saglio, G.
Pane, F.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2008, 93 : S39 - S39

← 1 2 3 4 5 →